Mean Arterial Pressure: Therapeutic Goals and Pharmacologic Support

Critical Care Clinics

Volumn 26, Issue 2, 2010, Pages 285-293

  Shapiro, David S ^a,b   Loiacono, Laurie A ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Mean arterial pressure; Sepsis; Septic shock; Vasopressors

Indexed keywords

ADRENALIN; DOPAMINE; HYPERTENSIVE FACTOR; NORADRENALIN; PHENYLEPHRINE;

BLOOD OXYGEN TENSION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD VESSEL TONE; CENTRAL VENOUS PRESSURE; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FLUID RESUSCITATION; HUMAN; MEAN ARTERIAL PRESSURE; MORTALITY; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT RESPONSE; VASOCONSTRICTION;

BLOOD PRESSURE; CARDIOTONIC AGENTS; CENTRAL VENOUS PRESSURE; DOPAMINE; FLUID THERAPY; HUMANS; OXYGEN; OXYGEN CONSUMPTION; PHENYLPROPANOLAMINE; SHOCK, SEPTIC; SYMPATHOMIMETICS; VASOCONSTRICTOR AGENTS;

EID: 77951148397     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.12.005     Document Type: Review

References (27)

1. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
2. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2008, 34:17-60.
3. Varpula M., Tallgren M., Saukkonen K., et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005, 31:1066-1071.
4. Hayes M.A., Timins A.C., Yau E.H., et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717-1722.
5. Gattinoni L., Brazzi L., Pelosi P., et al. A trial of goal-oriented hemodynamic therapy in critically ill patients: svO2 Collaborative Group. N Engl J Med 1995, 333:1025-1032.
6. Hollenberg S.M., Ahrens T.S., Annane D., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004, 32:1928-1948.
7. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care med 2000, 28:2729-2732.
8. DiGiantomasso D., May C.N., Bellomo R. Vital organ blood flow during sepsis. Chest 2003, 124:1053-1059.
9. Schlame M., Blanck T.J.J. Cardiovascular system. Civetta Taylor and Kirby's critical care 2009, 693-695. Lippincott Williams & Wilkins, Philadelphia (PA). 4th edition. A. Gabrielli, A.J. Layon, Y. Mihae (Eds.).
10. Darovic G.O. Cardiovascular anatomy and physiology. Hemodynamic monitoring: invasive and noninvasive clinical application 2002, 103-105. WB Saunders, Philadelphia (PA). 2nd edition. G.O. Darovi (Ed.).
11. Magner L.N. A history of the life sciences 2002, Marcel Dekker, Inc, Philadelphia (PA), p. 223-5.
12. Marino P.L. The ICU book 2007, Lippincott Williams & Wilkins, Philadelphia (PA), p. 151-4.
13. Bur A., Hirschl M., Vleck M., et al. Factors influencing the accuracy of oscillometric blood pressure measurements in critically ill patients. Crit Care Med 2003, 31:793-799.
14. Davis R.F. Clinical comparison of automated auscultatory and oscillometric and catheter-transducer measurements of arterial pressure. J Clin Monit 1985, 1:114-119.
15. Shlyakhto E., Conrady A. Korotkoff sounds: what do we know about its discovery?. J Hypertens 2005, 23:3-4.
16. Leone M., Martin C. Vasopressor use in septic shock: an update. Curr Opin Anesthesiol 2008, 21:141-147.
17. Bourgoin A., Leone M., Delmas A., et al. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005, 33:780-786.
18. Holmes C.L., Walley K.R. Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care 2009, 15:398-402.
19. Beale R.J., Hollenberg S.M., Vincent J.L., et al. Vasopressor and inotropic support in septic shock: an evidence based review. Crit Care Med 2004, 32:S455-S465.
20. Müllner M., Urbanek B., Havel C., et al. Vasopressors for shock. Cochrane Database Syst Rev 2004, (3). CD003709.
21. Levy B., Bollaert P.E., Charpentier C., et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997, 23:282-287.
22. Wakatsuki T., Nakaya Y., Inoue I. Vasopressin modulates K+ channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol 1992, 263:H491-H496.
23. Flancbaum L., Dick M., Dasta J.F., et al. A dose-response study of phenyleprhine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997, 51:461-465.
24. Martin C., Papazian L., Perrin G., et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993, 103:1826-1831.
25. Jhanji S., Stirling S., Patel N., et al. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 2009, 37:1961-1966.
26. Holmes C.L., Patel B.M., Russell J.A., et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120:989-1002.
27. Barrett B.J., Parfrey P.S. Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 2006, 34:379-386.